Rapid Micro Biosystems Announces New Vice President of Product Development by Seini Moimoi | Oct 11, 2016 | Portfolio News
Collegium Submits Supplemental New Drug Submission to FDA for Xtampza® ER by Seini Moimoi | Oct 5, 2016 | Portfolio News
Jazz Pharmaceuticals Initiates Rolling NDA Submission for Vyxeos (CPX-351) Expects to Complete NDA Submission by Early 2017 by Seini Moimoi | Oct 3, 2016 | Portfolio News
Collegium Submits New Drug Submission to Health Canada for Xtampza® ER, an Analgesic with Abuse-Deterrent Properties for the Treatment of Chronic Pain by Seini Moimoi | Oct 3, 2016 | Portfolio News
Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER by Seini Moimoi | Sep 29, 2016 | Portfolio News
